Academy Learn to Trade for FREE Copy Trading Webinars
Get it on Google Play
Download on the App Store
Trade +10,000 CFDs with Tight Raw Spreads. – Trade Now!
Top XM LEaderboard
Numeral Ltd. JSE: XII
– 0 (0%) Prices delayed 15 min · Last updated: —
Open
Prev close
Day range
Volume
52-wk range
— – —
Market cap
P/E Ratio
EPS (ZARc)
Dividend Yield
—%
DPS (ZARc)
Price performance
Intraday — 7D — 1M — 3M — 6M — 1Y — 3Y — 5Y — YTD —
Loading chart…
Key statistics
Market cap
EPS
P/E ratio
Div. yield—%
DPS
Issued shares
52-week range
R — R —
Price overview
Open
Previous close
Day range
Volume
52-week range— – —
Change 0 (0%)
P/E ratio
EPS
Dividend
Dividend yield—%
Important dates
  • Aug 2025 Interim
    Released 17 Oct 2025
  • Feb 2026
    Prev Year End
  • Feb 2026 Final
    Released 15 Jul 2026
  • 20 Jul 2026
    Today
  • 14 Aug 2026
    AGM Unconfirmed
  • Aug 2026
    Half Year
  • Aug 2026 Interim
    Unconfirmed for 16 Oct
  • Feb 2027
    Next Year End
  • Feb 2027 Final
    Unconfirmed for 15 Jul
Financial results
No financial data available.
Latest SENS announcements
  • Numeral final results February 2026
    2026-07-20 08:05:25
    Revenue for the period increased to USD2.2 million (USD974 816) with gross profit also increasing to USD1.7 million (USD775 821). Net profit attributed to owners of the parent decreased to USD79 939 (USD151 993). Furthermore, headline earnings per share lowered to USD0.0643 cents per share (USD0.122 cents per share). Dividend No dividends were authorised or paid during the period under review. Company prospects The Group’s principal operating focus remains biotechnology, health and pharmaceuticals. Recently the Company applied for an expanded business licence in order for the group to diversify into other industries, such as financial services, fintech, asset backed funding and debt-related opportunities where such opportunities are consistent with shareholder interests and subject to all required regulatory, listing and shareholder approvals. The licence was approved as announced on SEM and SENS subsequent to the year end. Numeral is dedicated to regrowing its healthcare and biotech business as well as embracing technological and commercial opportunities in the vertical. It will also seek to diversify the Group through strategic acquisitions and pursuing new distribution channels through innovative platforms and strategic partnerships.
  • Numeral final results February 2026
    2026-07-15 14:57:19
    Revenue for the period increased to USD2.2 million (USD974 816) with gross profit also increasing to USD1.7 million (USD775 821). Net profit attributed to owners of the parent decreased to USD79 939 (USD151 993). Furthermore, headline earnings per share lowered to USD0.0643 cents per share (USD0.122 cents per share). Dividend No dividends were authorised or paid during the period under review. Company prospects The Group’s principal operating focus remains biotechnology, health and pharmaceuticals. Recently the Company applied for an expanded business licence in order for the group to diversify into other industries, such as financial services, fintech, asset backed funding and debt-related opportunities where such opportunities are consistent with shareholder interests and subject to all required regulatory, listing and shareholder approvals. The licence was approved as announced on SEM and SENS subsequent to the year end. Numeral is dedicated to regrowing its healthcare and biotech business as well as embracing technological and commercial opportunities in the vertical. It will also seek to diversify the Group through strategic acquisitions and pursuing new distribution channels through innovative platforms and strategic partnerships.
  • Numeral - change statement & cautionary withdrawal
    2026-07-15 14:50:07
    Numeral Ltd. has restated its audited financial results for the year ending 28 February 2025 following a detailed review. Key amendments include significant restatements of assets, liabilities, and equity, notably an increase in non-current assets to USD3.1 billion and total assets to USD4.7 billion. The restatements corrected classification errors, updated fair values, and reflected deferred tax adjustments, resulting in a revised net profit of USD170 521 (restated) compared to USD181 934 previously. The restated results also led to the withdrawal of the previous cautionary announcement, indicating that shareholders can now trade without caution. The revised financial statements will be published around 15 July 2026.
  • Numeral - healthcare and biotech strategy
    2026-07-09 14:16:33
    The Board announced that Numeral has expanded its healthcare and biotechnology strategy through a number of strategic initiatives across the premium wellness, sports recovery and healthcare sectors.
  • Numeral - appointment of non-executive director
    2026-06-29 12:47:20
    Numeral appointed Kevin Evans as an independent non-executive director, effective 1 July 2026.
Peer comparison
Company Price (ZAR) Change Market cap
JSE (JSE) R 151.86 -0.56%
PURPLE (PPE) R 1.74 -0.57%
VUNANI (VUN) R 2.64 +0%
NUMERAL (XII) R 0.30 -9.09%

People Also Watch

1,032.54
168.18
188.21
31.65

Today's Verdict

Today's verdict: Numeral Ltd. price forecast signals a cautious stance, with dividend visibility limited and charts plus historical graph readings showing only modest growth momentum. The price today in rands is R0.3, leaving buy or sell decisions sensitive to cost discipline, for sale liquidity, and any shift in preference shares or payout expectations. Traders checking how to buy through an online trading account can use the share code XII and current data to judge whether the stock is suitable for active trading; the live graph remains the best guide for near-term prediction.

Live Share Data

LabelValue
Data as of2026-07-16 17:05:00
Share Name & TickerNumeral Ltd. (XII)
ExchangeJSE (Johannesburg Stock Exchange)
Sector & IndustrySector Name / Industry Name
Current Price0.3
Market Capitalization37.28m
P/E Ratio28.57
Dividend Yield
Trading Volume (Live Data)
Recent Price Change0

Numeral Ltd. Key Highlights

LabelValue
Current Price0.3, reflecting a 0 move from the previous close
Market Cap37.28m, indicating a small market presence
P/E Ratio28.57, suggesting fair valuation
Dividend Yield–, offering no current income stream
VolatilityModerate, based on the flat recent change and limited live volume visibility

Numeral Ltd. Limited Forecast Insights

Bullish or bearish bias remains restrained. With the price holding at R0.3 and no fresh volume signal provided, the near-term setup looks neutral. A clearer move would likely require stronger turnover, a catalyst tied to earnings, or a shift in sector sentiment on the JSE.

FAQ on Numeral Ltd. Shares

Q1: What are Numeral Ltd. shares?
Answer: Numeral Ltd. shares are equity instruments listed on the JSE under share code XII. The live price today is R0.3 per share, with a market capitalization of 37.28m and no dividend yield indicated in the current data.

Q2: How can I buy Numeral Ltd. shares?
Answer: To buy Numeral Ltd. shares, use a regulated JSE trading platform and place a trade using share code XII. The current price per share is R0.3, so your purchase size depends on the number of SHARES you want and your available capital.

Q3: What affects the price of Numeral Ltd. shares?
Answer: The price of Numeral Ltd. shares is affected by current valuation, trading interest, and market perception. With a P/E ratio of 28.57, market cap of 37.28m, and recent price change of 0, the share is currently trading in a stable range.

Q4: Does Numeral Ltd. pay dividends?
Answer: The live data shows a dividend yield of –, which means no current dividend income is indicated. Investors focused on yield should note that the present price per share is R0.3 and the market is not showing a listed payout figure.

Q5: How can I track my Numeral Ltd. shares and dividends?
Answer: Track Numeral Ltd. SHARES through your trading account and monitor JSE disclosures for updates on the share code XII. Since dividend yield is shown as –, there is no current dividend to track in the live data set provided.

Q6: What factors are affecting the Numeral Ltd. share price?
Answer: The share price is being shaped by its flat recent move of 0, the current price of R0.3, and a modest market cap of 37.28m. The P/E ratio of 28.57 also suggests investors are weighing valuation carefully.

Q7: Is Numeral Ltd. a good share to buy?
Answer: Based strictly on the live data, Numeral Ltd. may suit investors who are comfortable with a small-cap profile and a price per share of R0.3. The lack of dividend yield and unchanged price today suggest a cautious, data-led approach.

Q8: Is it advisable to buy Numeral Ltd. shares today?
Answer: The current data does not show a strong momentum signal, as the price today is R0.3 and recent change is 0. If you choose to buy, it should be after checking your risk tolerance, cost limits, and trading plan.

Q9: How much does one Numeral Ltd. share cost?
Answer: One Numeral Ltd. share costs R0.3 today. That price per share is unchanged in the live data, and the stock’s market cap of 37.28m places it in a smaller market category on the JSE.

Q10: How to sell Numeral Ltd. shares?
Answer: To sell Numeral Ltd. shares, log into your online trading account, select share code XII, and enter a sell order at your chosen price. With current trading volume not provided, liquidity should be checked before placing the trade.

How to Buy Numeral Ltd. Shares Step by Step

Open a FREE trading account.

Verify your account via email or phone number.

Set up 2FA for security.

Complete KYC verification.

Use the dashboard to review the market and trade setup.

Deposit fiat into your trading account.

Purchase Numeral Ltd. SHARES using share code XII.

Numeral Ltd. Actionable Financial Advice

Given Numeral Ltd.'s current performance, investors should HOLD the shares if prices move ABOVE the identified key levels. Monitor macroeconomic developments and sector conditions to refine your strategy.


Latest News On Numeral Ltd Shares
XM Footer

Recommended brokers

IC Markets Footer